ZIVO Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 21.50%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

ZIVO Bioscience Insider Trading History Chart

ZIVO Bioscience Share Price & Price History

^$21.00

▲ +0.04 (0.19%)

As of 11/21/2024 06:39 PM ET

Days: 30 | 90 | 365

Download Our Tesla Ebook For Free

From DTI | Ad

Like many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.

To claim your copy free of charge simply follow this link.

ZIVO Bioscience Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/2/2023	Mark E Strome	Major Shareholder	Buy	40,000	$4.99	$199,600.00	203,601
12/19/2022	Nola E Masterson	Director	Buy	50	$15.84	$792.00	866
9/14/2022	Christopher D. Maggiore	Director	Buy	1,200	$21.18	$25,416.00	135,050
2/11/2022	Christopher D. Maggiore	Director	Buy	7,494	$23.22	$174,010.68
2/9/2022	Christopher D. Maggiore	Director	Buy	4,727	$21.30	$100,685.10
1/27/2022	John Bernard Payne	Director	Buy	7	$15.00	$105.00
1/25/2022	John Bernard Payne	Director	Buy	1,520	$15.00	$22,800.00
1/11/2022	Christopher D. Maggiore	Director	Buy	1,260	$15.84	$19,958.40

Download Our Tesla Ebook For Free

From DTI | Ad

To claim your copy free of charge simply follow this link.

SEC Filings (Institutional Ownership Changes) for ZIVO Bioscience (NASDAQ:ZIVO)

12.83% of ZIVO Bioscience stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

ZIVO Bioscience Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/15/2023	Armistice Capital LLC	801,870	$1.04M	0.0%	-21.7%	46.084%
11/16/2021	Two Sigma Securities LLC	30,260	$0.14M	0.0%	N/A	0.326%
11/12/2021	Credit Suisse AG	45,132	$0.21M	0.0%	N/A	0.486%
8/11/2021	Commonwealth Equity Services LLC	31,636	$0.15M	0.0%	N/A	0.590%

Data available starting January 2016

ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. Its products indications include poultry gut health, bovine mastitis, canine joint health, human immune modification, algal biomass for human consumption, and biomass for supporting skin health / anti-aging. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is headquartered in Bloomfield Hills, Michigan.

Today's Range

Now: $21.00

$20.50

$21.00

50 Day Range

MA: $18.57

$13.00

$22.00

52 Week Range

Now: $21.00

$0.48

$22.15

Volume

791 shs

Average Volume

3,279 shs

Market Capitalization

$74.55 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.24

Who are the company insiders with the largest holdings of ZIVO Bioscience?: ZIVO Bioscience's top insider investors include:
Mark E Strome (Major Shareholder)
Nola E Masterson (Director)
Learn More about top insider investors at ZIVO Bioscience.